Skip to main content
Top
Published in: Diabetologia 11/2007

Open Access 01-11-2007 | Article

Relationship between glycated haemoglobin levels and mean glucose levels over time

Authors: D. M. Nathan, H. Turgeon, S. Regan

Published in: Diabetologia | Issue 11/2007

Login to get access

Abstract

Aims/hypothesis

HbA1c, expressed as the percentage of adult haemoglobin that is glycated, is the most widely used measure of chronic glycaemia. Achieving near-normal HbA1c levels has been shown to reduce long-term complications and the HbA1c assay is recommended to determine whether treatment is adequate and to guide adjustments. However, daily adjustments of therapy are guided by capillary glucose levels (mmol/l). We determined the relationship between an accurate measure of mean glucose levels over time and the HbA1c level, and whether HbA1c can be expressed in the same units as self-monitoring results.

Methods

Twenty-two participants with diabetes and three non-diabetic participants were included in this longitudinal observational study. Mean glucose levels were measured by continuous glucose monitoring (CGM), which measures interstitial glucose levels every 5 min, for 12 weeks. Capillary measurements were obtained four times per day to confirm the accuracy of CGM. HbA1c was measured at baseline and every 4 weeks.

Results

The HbA1c results at weeks 8 and 12 correlated strongly (r = 0.90) with the CGM results during the preceding 8 and 12 weeks. A curvilinear (exponential) relationship and a linear regression captured the relationship with similarly high correlations, which allowed transformation of HbA1c values to a calculated mean glucose level.

Conclusions and interpretation

HbA1c correlates closely with a complete measure of average glycaemia over the preceding 8–12 weeks. The translation of HbA1c to an average glucose level for reporting and management purposes is feasible.
Literature
1.
go back to reference Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295:1688–1697CrossRefPubMed Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295:1688–1697CrossRefPubMed
2.
go back to reference American Diabetes Association (2007) Standards of medical care of diabetes. Diabetes Care 30(Suppl 1):S4–S41CrossRef American Diabetes Association (2007) Standards of medical care of diabetes. Diabetes Care 30(Suppl 1):S4–S41CrossRef
3.
go back to reference Goldstein DE, Little R, Lorenz RA et al (2004) Tests of glycemia in diabetes. Diabetes Care 27:1761–1773CrossRefPubMed Goldstein DE, Little R, Lorenz RA et al (2004) Tests of glycemia in diabetes. Diabetes Care 27:1761–1773CrossRefPubMed
4.
go back to reference Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976) Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 295:417–420CrossRefPubMed Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976) Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 295:417–420CrossRefPubMed
5.
go back to reference Koenig RJ, Peterson CM, Kilo C, Cerami A, Williamson JR (1976) Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes 24:230–232CrossRef Koenig RJ, Peterson CM, Kilo C, Cerami A, Williamson JR (1976) Hemoglobin A1c as an indicator of the degree of glucose intolerance in diabetes. Diabetes 24:230–232CrossRef
6.
go back to reference Peterson CM, Jones RL, Dupuis A, Bernstein R, O’Shea M (1979) Feasibility of improved glucose control in patients with insulin dependent diabetes mellitus. Diabetes Care 2:329–335CrossRefPubMed Peterson CM, Jones RL, Dupuis A, Bernstein R, O’Shea M (1979) Feasibility of improved glucose control in patients with insulin dependent diabetes mellitus. Diabetes Care 2:329–335CrossRefPubMed
7.
go back to reference Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH (2004) Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am J Med Sci 327:319–323CrossRefPubMed Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH (2004) Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am J Med Sci 327:319–323CrossRefPubMed
8.
go back to reference Rohlfing CL, Wiedmeyer HM, Little R, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA1c in the diabetes control and complications trial. Diabetes Care 25:275–278CrossRefPubMed Rohlfing CL, Wiedmeyer HM, Little R, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA1c in the diabetes control and complications trial. Diabetes Care 25:275–278CrossRefPubMed
9.
go back to reference Svendsen PA, Lauritzen T, Soegaard U, Nerup J (1982) Glycosylated haemoglobin and steady-state mean blood glucose concentration in type I (insulin-dependent) diabetes. Diabetologia 23:403–405PubMed Svendsen PA, Lauritzen T, Soegaard U, Nerup J (1982) Glycosylated haemoglobin and steady-state mean blood glucose concentration in type I (insulin-dependent) diabetes. Diabetologia 23:403–405PubMed
10.
go back to reference Nathan DM, Singer DE, Hurxthal K, Goodson JD (1984) The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341–346CrossRefPubMed Nathan DM, Singer DE, Hurxthal K, Goodson JD (1984) The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341–346CrossRefPubMed
11.
go back to reference Diabetes Control and Complications Trial Research Group (1993) The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the diabetes control and complications trial. N Engl J Med 329:978–986 Diabetes Control and Complications Trial Research Group (1993) The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the diabetes control and complications trial. N Engl J Med 329:978–986
12.
go back to reference DCCT Research Group (1995) The association between glycemic exposure and long-term diabetic complications in the diabetes control and complications trial. Diabetes 44:968–983CrossRef DCCT Research Group (1995) The association between glycemic exposure and long-term diabetic complications in the diabetes control and complications trial. Diabetes 44:968–983CrossRef
13.
go back to reference UK Prospective Diabetes Study Group (1988) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853 UK Prospective Diabetes Study Group (1988) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
14.
go back to reference European Diabetes Policy Group (1999) A desk-top guide to type 2 diabetes mellitus. Diabet Med 16:716–730CrossRef European Diabetes Policy Group (1999) A desk-top guide to type 2 diabetes mellitus. Diabet Med 16:716–730CrossRef
15.
go back to reference Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetelogia 49:1711–1721CrossRef Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetelogia 49:1711–1721CrossRef
16.
go back to reference Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE (2001) The National Glycohemoglobin Standardization Program (NGSP): a five-year progress report. Clin Chem 47:1985–1992PubMed Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE (2001) The National Glycohemoglobin Standardization Program (NGSP): a five-year progress report. Clin Chem 47:1985–1992PubMed
17.
go back to reference Tahara Y, Shima K (1993) The response of GHb to stepwise plasma glucose over time in diabetic patients. Diabetes Care 9:1313–1314CrossRef Tahara Y, Shima K (1993) The response of GHb to stepwise plasma glucose over time in diabetic patients. Diabetes Care 9:1313–1314CrossRef
18.
go back to reference Bry L, Chen PC, Sacks DB (2001) Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47:153–163CrossRefPubMed Bry L, Chen PC, Sacks DB (2001) Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47:153–163CrossRefPubMed
19.
go back to reference Djakoure-Platonoff C, Radermercker R, Reach G, Slama G, Selam J-L (2003) Accuracy of continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab 29:159–162CrossRefPubMed Djakoure-Platonoff C, Radermercker R, Reach G, Slama G, Selam J-L (2003) Accuracy of continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab 29:159–162CrossRefPubMed
20.
go back to reference Clarke WL, Anderson S, Farhy L (2005) Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 28:2412–2417CrossRefPubMed Clarke WL, Anderson S, Farhy L (2005) Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 28:2412–2417CrossRefPubMed
21.
go back to reference Hassan Y, Johnson B, Nader N, Gannon MC, Nuttall FQ (2006) The relationship between 24-hour integrated glucose concentrations and % glycohemoglobin. J Lab Clin Med 147:21–26CrossRefPubMed Hassan Y, Johnson B, Nader N, Gannon MC, Nuttall FQ (2006) The relationship between 24-hour integrated glucose concentrations and % glycohemoglobin. J Lab Clin Med 147:21–26CrossRefPubMed
22.
go back to reference Virtue MA, Furne JK, Nuttall FQ, Levitt MD (2004) Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27:931–935CrossRefPubMed Virtue MA, Furne JK, Nuttall FQ, Levitt MD (2004) Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 27:931–935CrossRefPubMed
23.
go back to reference Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie SJ, Gould BJ (1990) Unexplained variability of glycated hemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208–215CrossRefPubMed Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie SJ, Gould BJ (1990) Unexplained variability of glycated hemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208–215CrossRefPubMed
24.
go back to reference Gould BJ, Davie SJ, Yudkin JS (1997) Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 260:49–64CrossRefPubMed Gould BJ, Davie SJ, Yudkin JS (1997) Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 260:49–64CrossRefPubMed
25.
go back to reference Hempe JM, Gomez R, McCarter RJ, Chalew SA (2002) High and low hemoglobin glycation phenotypes in type 1 diabetes. A challenge for interpretation of glycemic control. J Diabetes Complications 16:313–320CrossRefPubMed Hempe JM, Gomez R, McCarter RJ, Chalew SA (2002) High and low hemoglobin glycation phenotypes in type 1 diabetes. A challenge for interpretation of glycemic control. J Diabetes Complications 16:313–320CrossRefPubMed
Metadata
Title
Relationship between glycated haemoglobin levels and mean glucose levels over time
Authors
D. M. Nathan
H. Turgeon
S. Regan
Publication date
01-11-2007
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0803-0

Other articles of this Issue 11/2007

Diabetologia 11/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.